Overview

Dr. Kathy Griendling received her PhD in Cardiovascular Physiology from Johns Hopkins University. She is currently a Professor of Medicine in the Cardiology Division of Emory University and Executive Associate Dean for Faculty Affairs and Professional Development in the School of Medicine. Her research has been focused on the role of NADPH oxidases (Nox) in vascular biology and disease. She has a particular interest in how reactive oxygen species (ROS) derived from these enzymes regulate the signaling pathways leading to smooth muscle proliferation, migration and differentiation. Using transgenic and knockout mouse models, her laboratory has demonstrated a role for the NADPH oxidases in hypertension, collateral formation, vessel contraction and restenosis. Ongoing research is focused on Poldip2, a p22phox binding protein that regulates Nox4 activity and plays major roles in cell cycle progression, matrix regulation, and endothelial barrier function. Dr. Griendling has trained 46 post-doctoral fellows and PhD students, many of whom have successful academic careers. She is a member of the graduate faculty in Molecular and Systems Pharmacology.

Academic Appointment

• R. Wayne Alexander MD Professor of Medicine, Emory University School of Medicine
• Professor of Medicine, Emory University School of Medicine

Education

Research